Anneke Brand
#155,437
Most Influential Person Now
Anneke Brand's AcademicInfluence.com Rankings
Anneke Brandphilosophy Degrees
Philosophy
#8777
World Rank
#12221
Historical Rank
Logic
#5794
World Rank
#7233
Historical Rank

Anneke Brandbiology Degrees
Biology
#11943
World Rank
#15384
Historical Rank
Neuroscience
#1976
World Rank
#2032
Historical Rank

Download Badge
Philosophy Biology
Anneke Brand's Degrees
- PhD Neuroscience University of Amsterdam
- Masters Biomedical Sciences University of Amsterdam
- Bachelors Biology University of Amsterdam
Similar Degrees You Can Earn
Why Is Anneke Brand Influential?
(Suggest an Edit or Addition)Anneke Brand's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial (2016) (507)
- Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. (2001) (480)
- Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. (1999) (332)
- Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. (1999) (298)
- High‐dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy (1990) (285)
- Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components. (1981) (253)
- Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients (2006) (213)
- Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. (1993) (210)
- Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. (2004) (202)
- Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity (2006) (201)
- Double-Blind, Randomized Controlled Trial on the Effect of Leukocyte-Depleted Erythrocyte Transfusions in Cardiac Valve Surgery (2004) (200)
- Long‐term follow‐up of severe aplastic anaemia patients treated with antithymocyte globulin (1989) (188)
- Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products (1989) (181)
- Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction (2010) (169)
- Immunological aspects of blood transfusions. (2002) (166)
- Independent association of massive blood loss with mortality in cardiac surgery (2005) (163)
- Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. (1994) (157)
- Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests. (1978) (153)
- Alloimmunization after Leukocyte‐Depleted Multiple Random Donor Platelet Transfusions (1988) (141)
- Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement. (1991) (140)
- Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes (1991) (140)
- Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults (1988) (136)
- Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? (2006) (132)
- Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. (2012) (131)
- Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patients (1987) (129)
- Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies (1995) (126)
- Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome. (2007) (124)
- Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review (2010) (122)
- A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma. (2006) (121)
- Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery (2004) (115)
- Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens (1990) (108)
- Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it? (2003) (107)
- Splenectomy for the treatment of thrombotic thrombocytopenic purpura (2005) (107)
- Patient Blood Management in Elective Total Hip- and Knee-replacement Surgery (Part 1): A Randomized Controlled Trial on Erythropoietin and Blood Salvage as Transfusion Alternatives Using a Restrictive Transfusion Policy in Erythropoietin-eligible Patients (2014) (103)
- Lymphocyte-differentiating hormone of bursa of fabricius. (1976) (103)
- Red blood cell alloimmunization in sickle cell disease patients in Uganda (2010) (103)
- Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study. (1995) (102)
- The clinical impact of platelet refractoriness: correlation with bleeding and survival (2008) (100)
- Occurrence of Allogeneic HLA and Non-HLA Antibodies After Transfusion of Prestorage Filtered Platelets and Red Blood Cells: A Prospective Study (1995) (96)
- On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy (1990) (91)
- Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment. (1993) (89)
- Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. (2009) (89)
- The effects of pre- and postoperative fibrinogen levels on blood loss after cardiac surgery: a systematic review and meta-analysis. (2014) (87)
- Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective (2007) (85)
- Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1. (2005) (85)
- A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia. (2001) (83)
- HLA and RBC immunization after filtered and buffy coat‐depleted blood transfusion in cardiac surgery: a randomized controlled trial (2003) (80)
- Transfusion‐related acute lung injury reports in the Netherlands: an observational study (2010) (80)
- Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. (1995) (77)
- A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte‐depleted red blood cells (2010) (72)
- Patch: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial (2010) (71)
- Association of stress during delivery with increased numbers of nucleated cells and hematopoietic progenitor cells in umbilical cord blood. (2000) (70)
- Male‐only fresh‐frozen plasma for transfusion‐related acute lung injury prevention: before‐and‐after comparative cohort study (2011) (69)
- Transfusion‐related immunomodulation: a second hit in an inflammatory cascade? (2008) (68)
- Coagulation parameters of thawed fresh‐frozen plasma during storage at different temperatures (2007) (65)
- Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study (2005) (65)
- Clinical effects of leucoreduction of blood transfusions. (2011) (64)
- Long-term follow-up study of 168 patients with immune thrombocytopenia. Implications for therapy. (2009) (64)
- Postoperative complications associated with transfusion of platelets and plasma in cardiac surgery (2011) (64)
- Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial. (2018) (63)
- ABH antibodies causing platelet transfusion refractoriness (1986) (62)
- The impact of a restrictive transfusion trigger on post-operative complication rate and well-being following elective orthopaedic surgery: a post-hoc analysis of a randomised study. (2013) (62)
- The European Hematology Association Roadmap for European Hematology Research: a consensus document. (2016) (62)
- Autoantibodies to human endogenous retrovirus‐K are frequently detected in health and disease and react with multiple epitopes (2002) (58)
- HLA‐DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies (2014) (58)
- Intravenous Immunoglobulin in Neonates With Rhesus Hemolytic Disease: A Randomized Controlled Trial (2011) (58)
- Incidence of alloantibody formation after ABO‐D or extended matched red blood cell transfusions: a randomized trial (MATCH study) (2016) (57)
- Patient Blood Management in Elective Total Hip- and Knee-replacement Surgery (Part 2): A Randomized Controlled Trial on Blood Salvage as Transfusion Alternative Using a Restrictive Transfusion Policy in Patients with a Preoperative Hemoglobin above 13 g/dl (2014) (57)
- Effects of allogeneic leukocytes in blood transfusions during cardiac surgery on inflammatory mediators and postoperative complications* (2010) (57)
- Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood. (2003) (56)
- High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus. (2007) (54)
- Investigation of serum response to PMP22, connexin 32 and P0 in inflammatory neuropathies (2001) (53)
- Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies. (2003) (53)
- Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases (2010) (53)
- Triggers and appropriateness of red blood cell transfusions in the postpartum patient–a retrospective audit (2010) (52)
- Risk factors for complications in donors at first and repeat whole blood donation: a cohort study with assessment of the impact on donor return. (2014) (51)
- Spontaneous recovery from the Guillain-Barré syndrome is associated with anti-idiotypic antibodies recognizing a cross-reactive idiotype on anti-neuroblastoma cell line antibodies. (1993) (51)
- Clonal B-cell populations in patients with idiopathic thrombocytopenic purpura. (1990) (48)
- Polyvalent immunoglobulin for intravenous use interferes with cell proliferationin vitro (1992) (48)
- Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients (2009) (47)
- Effects of Storage of Red Cells (2008) (46)
- Follow up of children after antenatal treatment for alloimmune thrombocytopenia. (2004) (46)
- On the role of HLA antibodies in hematopoietic stem cell transplantation. (2013) (46)
- Is female sex a risk factor for red blood cell alloimmunization after transfusion? A systematic review. (2012) (46)
- Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura (2013) (44)
- Anti‐neuroblastoma cell line antibodies in inflammatory demyelinating polyneuropathy (1988) (44)
- Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy (1987) (43)
- Modulation of the alloimmune response by blood transfusions. (2001) (43)
- The number of nucleated cells reflects the hematopoietic content of umbilical cord blood for transplantation (1999) (43)
- Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells. (1988) (41)
- Induction of additional red cell alloantibodies after intrauterine transfusions (1994) (41)
- Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells (1991) (41)
- Ex vivo culture of human CD34+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model. (2006) (40)
- Antifibrinolytics attenuate inflammatory gene expression after cardiac surgery. (2013) (40)
- Potential use of autologous umbilical cord blood red blood cells for early transfusion needs of premature infants (2006) (40)
- A clinical study on the feasibility of autologous cord blood transfusion for anemia of prematurity (2008) (39)
- Thrombocytopaenia and intraventricular haemorrhage in very premature infants: a tale of two cities (2012) (38)
- Immunomodulation by blood transfusions. (2000) (38)
- Regulation of Autoantibodies in Inflammatory Demyelinating Polyneuropathy: Spontaneous and Therapeutic (1989) (38)
- The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response. (2005) (37)
- Survival of donor cells 25 years after intrauterine transfusion. (2000) (37)
- Lymphokine-activated killer cells selectively kill tumor cells in bone marrow without compromising bone marrow stem cell function in vitro (1989) (37)
- Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia? (2006) (37)
- Management of Severe Hemolytic Disease with Ultrasound‐Guided Intravascular Fetal Transfusions (1990) (37)
- Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg) (1994) (37)
- Passenger leukocytes, cytokines, and transfusion reactions. (1994) (36)
- Intravenous Immunoglobulins without Initial and Follow-Up Cordocentesis in Alloimmune Fetal and Neonatal Thrombocytopenia at High Risk for Intracranial Hemorrhage (2005) (36)
- Microbial contamination of cord blood stem cells (2002) (36)
- Postoperative anemia after joint replacement surgery is not related to quality of life during the first two weeks postoperatively (2011) (35)
- Is increased mortality associated with post‐operative infections after leukocytes containing red blood cell transfusions in cardiac surgery? An extended analysis (2007) (35)
- HLA class I‐eluted platelets as an alternative to HLA‐matched platelets (1996) (35)
- Thymopoietin and bursopoietin: induction signals regulating early lymphocyte differentiation. (1977) (33)
- Tolerance of intraoperative hemoglobin decrease during cardiac surgery (2014) (33)
- Human retrovirus-5 in rheumatic disease. (1999) (31)
- Double umbilical cord blood transplantation: a study of early engraftment kinetics in leukocyte subsets using HLA-specific monoclonal antibodies. (2013) (31)
- Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer-cell cytotoxicity. (1992) (30)
- Pretransplant blood transfusions revisited: a role for CD4+ regulatory T cells?1 (2004) (30)
- Bu-1 andTh-1, two loci determining surface antigens of B or T lymphocytes in the chicken (1976) (30)
- Mannose‐binding lectin is involved in multiple organ dysfunction syndrome after cardiac surgery: effects of blood transfusions (2008) (29)
- Antenatal care in pregnancies at risk of alloimmune thrombocytopenia: report of 19 cases in 16 families. (1996) (29)
- Transfusion Results of Filtered and Subsequently Stored Random Platelet Suspensions Prepared from Buffy Coats (1992) (29)
- Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIG (2007) (29)
- Exchange transfusions and top‐up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease (2011) (28)
- Increased numbers of circulating haematopoietic progenitor cells after treatment with high‐dose interleukin‐2 in cancer patients (1990) (28)
- ABO incompatible stem cell transplantation in children does not influence outcome (2007) (28)
- Maternal red blood cell alloimmunisation in South Western Uganda (2011) (28)
- Viability does not necessarily reflect the hematopoietic progenitor cell potency of a cord blood unit: results of an interlaboratory exercise (2008) (27)
- Blood component therapy in bone marrow transplantation. (1984) (27)
- Modulation of the T cell compartment by blood transfusion. Effect on cytotoxic and helper T lymphocyte precursor frequencies and T cell receptor Vbeta usage. (1997) (27)
- The immunologic profile of infants born after maternal immunoglobulin treatment and intrauterine platelet transfusions for fetal/neonatal alloimmune thrombocytopenia. (2004) (27)
- Female sex of older patients is an independent risk factor for red blood cell alloimmunization after transfusion (2015) (26)
- Top‐up transfusions in neonates with Rh hemolytic disease in relation to exchange transfusions (2010) (26)
- In vitro effects of polyvalent immunoglobulin for intravenous use. (1994) (25)
- The use of cord blood for transfusion purposes: current status (2009) (25)
- Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT). (1989) (25)
- Neonatal Morbidity after Exchange Transfusion for Red Cell Alloimmune Hemolytic Disease (2012) (25)
- A study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products: the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial (2016) (25)
- Immunological complications of blood transfusions. (2016) (25)
- Effect of maternal anti‐HPA‐1a antibodies and polyclonal IVIG on the activation status of vascular endothelial cells (2004) (25)
- Alloimmune platelet refractoriness:incidence declines, unsolved problems persist (2001) (24)
- Long-Term follow up after intra-Uterine transfusionS; the LOTUS study (2010) (23)
- Platelet preservation V. Survival, serotonin uptake velocity, and response to hypotonic stress of fresh and cryopreserved human platelets (1977) (23)
- Hemostatic alterations during coronary artery bypass grafting. (2016) (23)
- The role of pathogen‐reduced platelet transfusions on HLA alloimmunization in hemato‐oncological patients (2018) (23)
- Does a Platelet Transfusion Independently Affect Bleeding and Adverse Outcomes in Cardiac Surgery? (2017) (23)
- Severe fetal thrombocytopenia in Rhesus D alloimmunized pregnancies. (2008) (23)
- The reduction of HLA class I expression on platelets: a potential approach in the management of HLA-alloimmunized refractory patients. (1999) (23)
- HLA antigens in patients with chronic inflammatory demyelinating polyneuropathy (1991) (23)
- Immediate and long-term somatic effects, and health-related quality of life of BM donation during early childhood. A single-center report in 210 pediatric donors (2013) (22)
- RECOVERY OF HEMATOPOIESIS AFTER BLOOD‐GROUP‐INCOMPATIBLE BONE MARROW TRANSPLANTATION WITH RED‐BLOOD‐CELL‐DEPLETED GRAFTS (1985) (22)
- Protective effect of blood transfusions on postoperative recurrence of Crohn's disease in parous women (1994) (22)
- Haematopoietic and immunologic abnormalities in severe aplastic anaemia patients treated with anti‐thymocyte globulin (1989) (22)
- Intraoperative Anemia and Single Red Blood Cell Transfusion During Cardiac Surgery: An Assessment of Postoperative Outcome Including Patients Refusing Blood Transfusion. (2016) (22)
- Noninherited maternal antigens identify acceptable HLA mismatches: benefit to patients and cost-effectiveness for cord blood banks. (2014) (22)
- Coagulation parameters of CPD fresh-frozen plasma and CPD cryoprecipitate-poor plasma after storage at 4 degrees C for 28 days. (1993) (21)
- Compliance with prophylactic platelet transfusion trigger in haematological patients (2005) (21)
- The HLA‐DRB1*15 phenotype is associated with multiple red blood cell and HLA antibody responsiveness (2016) (21)
- Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer (2009) (21)
- Effects of a nonapeptide FTS on lymphocyte differentiations in vitro (1977) (21)
- Monitoring of indirect allorecognition: wishful thinking or solid data? (2007) (20)
- Differential Effect of Pretransplant Blood Transfusions on Immune Effector and Regulatory Compartments in HLA-Sensitized and Nonsensitized Recipients (2010) (20)
- Exclusive TCRVbeta chain usage of ex vivo generated minor Histocompatibility antigen HA-1 specific cytotoxic T cells: implications for monitoring of immunotherapy of leukemia by TCRBV spectratyping. (2002) (20)
- Efficacy, safety and user‐friendliness of two devices for postoperative autologous shed red blood cell re‐infusion in elective orthopaedic surgery patients: a randomized pilot study (2006) (20)
- Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study (2014) (20)
- Clinical outcomes after peripheral blood stem cell donation by related donors: a Dutch single‐center cohort study (2013) (20)
- The effect of perioperative blood transfusion on recurrence after primary operation for Crohn's disease. (1991) (19)
- Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with β‐thalassemia: challenges in treatment (2010) (19)
- Beneficial effect of intravenous gammaglobulin in a patient with complement‐mediated autoimmune thrombocytopenia due to IgM‐anti‐platelet antibodies (1988) (19)
- In vivo tracking of transfused platelets for recovery and survival studies: an appraisal of labeling methods. (2010) (19)
- Prenatal Management of Fetal Alloimmune Thrombocytopenia: Editorial (1993) (19)
- A sensitive quantitative single‐platform flow cytometry protocol to measure human platelets in mouse peripheral blood (2007) (18)
- The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent (2017) (18)
- The Growth Arresting Effect of Human Immunoglobulin for Intravenous Use Is Mediated by Antibodies Recognizing Membrane Glycolipids (1997) (18)
- Bone marrow histopathology of patients with severe aplastic anaemia before treatment and at follow‐up (1989) (18)
- Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens? (2008) (18)
- Multiple‐laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood (2006) (18)
- Lymphokine-activated killer cells selectively kill tumor cells in bone marrow without compromising bone marrow stem cell function in vitro. (1989) (18)
- Intravenous immunoglobulins and transforming growth factor β (1998) (18)
- Extended matched intrauterine transfusions reduce maternal Duffy, Kidd, and S antibody formation (2015) (18)
- Processing cord blood from premature infants into autologous red‐blood‐cell products for transfusion (2011) (17)
- Platelets from donors with consistently low HLA-B8, -B12, or -B35 expression do not undergo antibody-mediated internalization. (2018) (17)
- Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients (2015) (17)
- Selective outgrowth of CD45RO+ V gamma 9+/V delta 2+ T-cell receptor gamma/delta T cells early after bone marrow transplantation. (1991) (17)
- Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand (2020) (16)
- Red blood cell alloimmunization from an African perspective (2010) (16)
- Cost‐effectiveness of leucocyte‐depleted erythrocyte transfusion in cardiac valve surgery (2005) (16)
- LEUCOCYTOCLASTIC VASCULITIS DURING GM‐CSF THERAPY (1989) (16)
- Platelet transfusion therapy: from 1973 to 2005. (2006) (15)
- Postnatal outcome in neonates with severe Rhesus c compared to Rhesus D hemolytic disease (2013) (15)
- Cytomegalovirus immunity in allogeneic marrow grafting. (1985) (15)
- Prediction of nucleated cells in bone marrow stem cell products by donor characteristics: a retrospective single centre analysis (2010) (15)
- Quality controls of cryopreserved haematopoietic progenitor cells (peripheral blood, cord blood, bone marrow) (2011) (15)
- Cell-mediated lysis of human hematopoietic progenitor cells. (1987) (14)
- The observation of bleeding complications in haemato‐oncological patients: stringent watching, relevant reporting (2012) (14)
- Prevention and diagnosis of delayed haemolytic transfusion reactions (2006) (14)
- Prenatal management of fetal alloimmune thrombocytopenia. (1993) (14)
- Functional Characterization of TPO‐Expanded CD34+ Cord Blood Cells Identifies CD34−CD61− Cells as Platelet‐Producing Cells Early After Transplantation in NOD/SCID Mice and rCD34+ Cells as CAFC Colony‐Forming Cells (2012) (14)
- The kinetics of HLA class I elution and the relevance for the use of HLA‐eluted platelet transfusions (1996) (13)
- Intravenous immunoglobulins and transforming growth factor beta. (1998) (13)
- Cost‐effectiveness of leucocyte depletion of red‐cell transfusions for patients undergoing cardiac surgery (2003) (13)
- Prospective validation of the EuroSCORE II risk model in a single Dutch cardiac surgery centre (2018) (13)
- A comparative cohort study on transfusion practice and outcome in two Dutch tertiary neonatal centres (2009) (13)
- Lymphoma-associated paraneoplastic digital ischemia (2014) (13)
- Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation. (1993) (13)
- A comparison of volume‐reduced versus standard HLA/HPA–matched apheresis platelets in alloimmunized adult patients (2012) (13)
- Escherichia coli-nitroreductase suicide gene control of human telomerase reverse transcriptase-transduced minor histocompatibility antigen-specific cytotoxic T cells (2004) (13)
- Hb Malmö [β-97(FG-4)His→Gln] leading to polycythemia in a Dutch family (1996) (13)
- Intravenous immunoglobulin treatment in hematological diseases (1998) (13)
- UV‐irradiated platelets: Ready to use? (1989) (12)
- Immunological aspects of blood transfusions. (2000) (12)
- Long-term outcome in relationship to neonatal transfusion volume in extremely premature infants: a comparative cohort study (2011) (12)
- Lymphokine-activated killer cell functions in patients with leukemic B-lymphoproliferative diseases. (1989) (12)
- The importance of non-HLA systems and the feasibility of the use of unrelated donors in bone marrow transplantation. (1978) (12)
- The clinical benefit of blood transfusion: a hypothetical experiment based on a nationwide survey of severe maternal morbidity (2013) (12)
- High anti‐HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother–child HLA triplet mismatches, high anti‐D titer, and new red blood cell antibody formation (2013) (11)
- Immunomodulation and remyelination: two aspects of human polyclonal immunoglobulin treatment in immune mediated neuropathies? (1997) (11)
- Kell alloimmunization in pregnancy: associated with fetal thrombocytopenia? (2008) (11)
- The use of blood products in perinatal medicine. (2008) (11)
- The effect of RBC transfusions on cytokine gene expression after cardiac surgery in patients developing post‐operative multiple organ failure (2011) (11)
- Stopping antiplatelet medication before coronary artery bypass graft surgery: is there an optimal timing to minimize bleeding? (2015) (11)
- Clinical significance of leukoreduktion of blood components. (2000) (11)
- Alterations in cord blood leukocyte subsets of patients with severe hemolytic disease after intrauterine transfusion therapy. (1997) (10)
- Acquired Zwa antigen on Zwa negative platelets demonstrated by Western blotting (1989) (10)
- Monitoring and treatment of anti‐D in pregnancy (2010) (10)
- Bursal and thymic alloantigen expression in lymphoid tissues of the chicken. (1975) (9)
- [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995]. (1999) (9)
- Thrombocytopenia at birth in neonates with red cell alloimmune haemolytic disease (2012) (9)
- GUIDELINES FOR THE TRANSFUSION OF RED CELLS (2008) (9)
- Multicentre randomized clinical trial to investigate the cost‐effectiveness of an allogeneic single‐donor fibrin sealant after coronary artery bypass grafting (FIBER Study) (2015) (9)
- Medical student education in transfusion medicine: Proposal from the "European and Mediterranean initiative in transfusion medicine". (2018) (9)
- On the presence of reverse transcriptase in myelo‐ and lymphoproliferative disorders (1979) (9)
- T‐cell prolymphocytic leukemia with an unusual phenotype CD4+ CD8+ (1987) (9)
- Association of HLA-DR2 antigen with serum IgG antibodies against Borrelia burgdorferi in Bannwarth's syndrome (1988) (8)
- Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions (2015) (8)
- Anti-D immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. (1995) (8)
- Posttransfusion platelet increments after different platelet products in neonates: a retrospective cohort study (2013) (8)
- Acute Management of Hemostasis in Patients With Neurological Injury. (2017) (8)
- Blood transfusions in neonatal cardiac surgery and ECMO (2009) (8)
- A Multi‐Center Prospective Randomized Trial of Buffy Coat Depleted‐ and Leukocyte Filtered Erythrocyte Transfusions in Vascular‐ and Gastrointestinal Oncologic Surgery (2002) (8)
- Protocolled Blood Transfusions in Recipients of a Simultaneous Pancreas–Kidney Transplant Reduce Severe Acute Graft Rejection (2008) (8)
- A life‐threatening episode of treatment‐resistant haemolysis in a pregnant patient with dyserythropoietic anaemia (CDA) type I (2012) (8)
- Severe Fetal Hemolysis and Cholestasis Due to High-Titer Maternal IgG Anti-A Antibodies (2019) (8)
- Intrauterine transfusions influence fetal leukocyte counts and subsets (1998) (8)
- Intrauterine transfusions affect fetal T-cell immunity. (1997) (7)
- Prevention of bleeding tendency after open-heart surgery for Tetralogy of Fallot. (1977) (7)
- The association between haemorrhage and markers of endothelial insufficiency and inflammation in patients with hypoproliferative thrombocytopenia: a cohort study (2019) (6)
- Anti‐K formation is not associated with the storage time of transfused red blood cells (2015) (6)
- The mechanism of action of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy. (1990) (6)
- [Activity loss of Von Willebrand factor cleaving protein (ADAMTS-13) is diagnostic for primary and pregnancy-related thrombotic thrombocytopenic purpura]. (2004) (6)
- Predictors for successful PBSC collection on the fourth day of G‐CSF‐induced mobilization in allogeneic stem cell donors (2017) (6)
- [Revision of the guideline 'Blood transfusion': for the newborn]. (2012) (6)
- [Evaluation of gradual conversion to a less invasive therapeutic strategy for pregnant women with alloimmune thrombocytopenia in the fetus for prevention of intracranial hemorrhage]. (2000) (6)
- Granulocyte transfusions for pediatric patients and the establishment of national treatment guidelines and donor registry. (2009) (6)
- Anti-βubulin antibodies have no diagnostic value in patients with chronic inflammatory demyelinating polyneuropathy (1995) (6)
- Exploring the use of expanded erythroid cells for autologous transfusion for anemia of prematurity (2013) (6)
- In vitro investigation of immunoglobulin treatment mechanisms in autoimmune diseases. (1996) (6)
- Misleading Results in the Determination of Haemolytic Disease of the Newborn Using Antibody Titration and ADCC in a Woman with Anti‐Lu b (1992) (5)
- LEUKOCYTE‐POOR BLOOD: ARGUMENTS AND GUIDELINES (1994) (5)
- Validation of human monoclonal HLA Class I antibodies to evaluate the kinetics of donor chimerism in different cell subsets after double‐cord‐blood transplantation in the NOD/SCID model (2013) (5)
- Immunomodulation and Allogeneic Blood Transfusion (2008) (5)
- Long-term risk of cancer development in adult patients with idiopathic aplastic anemia after treatment with anti-thymocyte globulin (2017) (4)
- Polymicrogyria in a neonate with severe autoimmune thrombocytopenia: rare coincidence or related disorder? (2007) (4)
- Hb Malmö [beta-97(FG-4)His-->Gln] leading to polycythemia in a Dutch family. (1996) (4)
- Allogeneic leukocytes in cardiac surgery: Good or bad? (2011) (4)
- Comparison between clonogenic and cytotoxic assays for measuring LAK cell activity. (1989) (4)
- Thrombopoietin treatment of one graft in a double cord blood transplant provides early platelet recovery while contributing to long-term engraftment in NSG mice. (2015) (4)
- Bone marrow transplantation or chemotherapy as post-remission treatment of adult acute myelogenous leukemia (1991) (4)
- Thrombocytopenia and intraventricular hemorrhage in very premature infants: a tale of two cities (2011) (3)
- STORAGE TIME OF TRANSFUSED BLOOD IN THE INTENSIVE CARE UNIT: 579 (2004) (3)
- Anti-beta-tubulin antibodies have no diagnostic value in patients with chronic inflammatory demyelinating polyneuropathy. (1995) (3)
- Does blood transfusion increase risk of postoperative complications? (2003) (3)
- Erythrocyte survival tests in cases of anti‐AnWj antibodies (2009) (3)
- IVIG treatment in chronic inflammatory demyelinating polyneuropathy (1991) (3)
- D antibodies in pregnant women in multiethnic Suriname: the observational RheSuN study (2017) (3)
- A new preparation method for red blood cells for intrauterine transfusion enabling reduction of donor exposure (2015) (3)
- Medical student education in transfusion medicine, part II: Moving forward to building up a "Know How" education program in transfusion medicine for under-graduate medical students. (2020) (3)
- Exposure to non-inherited maternal antigens by breastfeeding affects antibody responsiveness (2018) (3)
- Cryopreservation of cord blood CD34+ cells before or after thrombopoietin expansion differentially affects early platelet recovery in NOD SCID mice (2015) (3)
- Leucocyte contamination of platelet products. (1994) (2)
- Impact of Photodynamic Treatment with Meso‐substituted Porphyrin on the Immunomodulatory Capacity of White Blood Cell‐containing Red Blood Cell Products (2010) (2)
- When selecting a cord blood unit from a firstborn donor verify that the patient shares an Ag with the unit that is foreign to the mother of the donor (2017) (2)
- Antibodies to sulfatide in leprosy and leprosy reactions. (1999) (2)
- Cost effectiveness of leukocyte depletion. (1994) (2)
- [Need for blood transfusion in premature infants in 2 Dutch perinatology centres particularly determined by blood sampling for diagnosis]. (2008) (2)
- [Thrombotic thrombocytopenic purpura in 13 Dutch centres: treatment and longterm follow-up]. (1997) (2)
- No Synergistic Effect of Cotransplantation of MSC and Ex Vivo TPO-Expanded CD34(+) Cord Blood Cells on Platelet Recovery and Bone Marrow Engraftment in NOD SCID Mice. (2015) (2)
- POST‐TRANSFUSION THROMBOCYTOPENIA (1989) (2)
- Oligoclonal Development of Germinal Centre Cells as Detected by Anti‐Idiotype Antibodies (1993) (2)
- Fetal, neonatal and paediatric transfusion medicine (2007) (2)
- Blood transfusion and constituent transfusion. (1989) (2)
- [Paroxysmal nocturnal hemoglobinuria in pregnancy]. (1998) (2)
- Platelet supportive care: immunological and clinical aspects. (1979) (2)
- Male-only fresh frozen plasma for TRALI prevention Before-and-after comparative cohort study (2011) (2)
- 522: Severe fetal thrombocytopenia and hydrops in Rh-D alloimmunized pregnancies: Independent risk factors (2007) (2)
- Half a century of Dutch transplant immunology. (2014) (2)
- Selective Outgrowth of CD 45 RO ' Vy 9 + / V 62 + T-cell Receptor y / S T Cells Early After Bone Marrow Transplantation (2003) (1)
- Modulation of the T cell compartment by blood transfusion: The effect on cytotoxic and helper T lymphocyte precursor frequencies and T cell receptor repertoire BV usage (1997) (1)
- Success in achieving a targeted platelet dose: What dose are we actually giving? (2003) (1)
- Fetal induced red blood cell antibodies persist over 20 years (2010) (1)
- Antenatal care in alloimmune thrombocytopenia (NAITP): Report of 20 cases in 18 families (1995) (1)
- Sensitization by platelet transfusion. (1991) (1)
- Obstetric transfusion practice (2016) (1)
- Prevalence of positive direct antiglobulin test and clinical outcomes in Surinamese newborns from D‐negative women (2017) (1)
- [Immunotherapy of cancer with interleukin-2 and with interleukin-2 activated cells]. (1989) (1)
- Reply to Mannacio et al. (2016) (1)
- Alloimmunization and Platelet Transfusion Refractoriness (1993) (1)
- [Treatment of acute myelogenous leukemia in adults; an account of the years 1968 to 1975]. (1977) (1)
- Transfer of 51CR Platelets and 51Chromium Ions Across the Term Rhesus Monkey Placenta (1978) (1)
- Comment on "Effect of storage time of transfused plasma on early and late mortality after coronary artery bypass grafting". (2011) (1)
- Interim Analysis on a Dutch HOVON Multicenter Randomized Open Label Phase II Trial on 3 Rituximab Dosing Schemes In Chronic ITP Patients. (2010) (1)
- [Immunological effects of erythrocyte and leukocyte transfusion. Work Group Blood Group Serology of the Medical Advisory Commission of the College for Blood Transfusion of the Netherlands Red Cross]. (1997) (1)
- [Prenatal treatment of allo-immune thrombocytopenia using high-dose IgG]. (1993) (1)
- 54: Long term follow-up after intra-uterine transfusions: the LOTUS study (2011) (1)
- [Reversible thrombocytopenia and polyneuropathy: the pleiotropic aspects of hypothyroidism]. (2010) (1)
- Immune reactivity in relationto cytomegalovirusinfection after allogeneic bone marrow transplantation (1985) (1)
- Protective effect of blood transfusions on postoperative recurrence of Crohn's disease in parous women. (1994) (1)
- Jon van Rood: The pioneer and his personal view on the early developments of HLA and immunogenetics. (2019) (1)
- Anti-β-tubulin antibodies in patients with chronic inflammatory demyelinating polyneuropathy (1994) (1)
- Intravenous gamma-globulin combined with platelet transfusions as treatment for a patient with acute lymphatic leukaemia and non-specific antiplatelet antibodies. (1986) (1)
- Frequency and characterization of RHD variants in serologically D– Surinamese pregnant women and D– newborns (2019) (1)
- Factors influencing platelet survival during antilymphocyte globulin treatment (1984) (1)
- The effects of pre-and postoperative fi brinogen levels on blood loss after cardiac surgery : a systematic review and meta-analysis (2014) (1)
- Uniform examination of stem cell donors (2011) (1)
- Foetal and Neonatal Immunohaematological Responses: Consequences for Practical Management? (2005) (1)
- HLA-elution, different preparation techniques and platelet viability (1998) (1)
- Granulocyte antigens recognized by allo antibodies (1984) (0)
- MODULATION OF THE T CELL COMPARTMENT BY BLOOD TRANSFUSION (2019) (0)
- 9 Exchange transfusions and top-up transfusions in neonates with Kell hemolytic disease compared to Rh D hemolytic disease (2012) (0)
- Successful Adoptive Immunotransfers in a Boy with Relapse of T-ALL After Bone Marrow Transplantation from an Unrelated Donor (1994) (0)
- Long term RBC and HLA antibody follow-up after intra-uterine transfusions (2010) (0)
- Painful myositis in the anti-synthetase syndrome with anti-PL12 antibodies (2010) (0)
- O764 THE CLINICAL BENEFIT OF BLOOD TRANSFUSION; A HYPOTHETICAL EXPERIMENT BASED ON A NATIONWIDE SURVEY OF SEVERE MATERNAL MORBIDITY (2012) (0)
- 419: Health-related quality of life and behavioral outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn (2012) (0)
- Fetal microchimerism may play a role in persistent fetal induced RBC antibody formation (2011) (0)
- High Levels of Circulating Hematopoietic Progenitor Cells after Continuous Infusion of High Dose Interleukin-2 in Cancer Patients (1991) (0)
- 67 Clinical and immunological follow uo of infants born after platelet transfusions and transplacental immunoglobulin treatment (2001) (0)
- UvA-DARE ( Digital Academic Repository ) PATCH : platelet transfusion in cerebral haemorrhage : study protocol for a multicentre , randomised , controlled trial (2010) (0)
- [Application of leukocyte-poor blood products. Work Group Blood Group Serology from the Medical Advisory Commission of the College for Blood Transfusion]. (1995) (0)
- Lymphokine-Activated Killer Cell Functions in Patients With Leukemic (1989) (0)
- Immunomodulation: Facts and Interpretations (2001) (0)
- The Official Requirements for Platelet Concentrates (1998) (0)
- Erythropoietin levels in premature neonates in relation to red blood cell transfusions (2013) (0)
- The independent effect of a platelet transfusion on bleeding and adverse outcomes in cardiac surgery (2016) (0)
- HS2 COST-EFFECTIVENESS OF LEUKODEPLETION IN MAJOR CARDIAC SURGERY (2002) (0)
- Umbilical cord blood transplantation in adult patients using double cord blood units (2008) (0)
- The importance of non-HLA sytems and the feasibility of the use of unrelated donors in bone marrow transplantation [proceedings]. (1978) (0)
- System-Restricted Minor Histocompatibility Antigens Generated Cytotoxic T Lymphocytes Specific for Hematopoietic - Feasibility of Immunotherapy of Relapsed Leukemia With Ex Vivo (2013) (0)
- Chapter 5. Immunomodulation and Allogeneic Blood Transfusion (2010) (0)
- [Subspecialty blood transfusion medicine]. (1998) (0)
- [Prevention of HLA alloimmunization due to platelet transfusion]. (1988) (0)
- Clinical significance of tissue antigens (1985) (0)
- [Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia]. (1978) (0)
- Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia: Is it safe? (2004) (0)
- Comparison of different blood sample processing methods for sensitive detection of low level chimerism by RHD real-time PCR assay (2013) (0)
- 576 Interaction of anti-HPA-1a-antibodies and therapeutic immunoglobulin with vascular endothelial cells (2001) (0)
- The diagnostic value of anti-GM1 antibodies in patients with motor syndromes (1994) (0)
- Early Engraftment Kinetics of Leukocyte Subsets by Means of HLA-Specific Mabs After Double Umbilical Cord Blood Transplantation Show a Very Rapid Induction of Single Complete Donor Chimerism. (2009) (0)
- In Vivo Versus Ex Vivo Modulation of Lymphocytes; Immunotherapy for Hematological Malignancies (1991) (0)
- No protective effect of NIMA on antibody production in women transfused for severe hemolytic disease of the fetus (2012) (0)
- 64-OR: Differential Effect of Pre-Transplant Blood Transfusions on Immune Effector and Regulatory Compartments in HLA-Sensitized- and Non-Sensitized Recipients (2010) (0)
- Faculty Opinions recommendation of The influence of baseline hemoglobin concentration on tolerance of anemia in cardiac surgery. (2008) (0)
- Prevention and diagnosis of delayed haemolytic transfusion reactions (2006) (0)
- The prognosis of aplastic anaemia (AA) and the indication for bone marrow transplantation [proceedings]. (1978) (0)
- Feasibility of adaptive immunotherapy of leukemia with HA-1 minor histocompatibility peptide specific cytotoxic T cells: A preclinical study (1997) (0)
- Frequency determination of RhD specific B‐lymphocytes in RhD antagonism (2000) (0)
- sulfatide antibodies in leprosy and leprosy reactions (2000) (0)
- Management of Alloimmunized, Refractory Patients in Need of Platelet Transfusions (1997) (0)
- Whole Blood Transcriptomic Responses After Cardiac Surgery Identify Gene Signatures Associated with Multiple Organ Failure and Transfusion (2011) (0)
- Parents’ Commitment to Participation in Mesenchymal Stem Cell Donation and Research Demonstrates Extensive Altruism to Other Patients. (2007) (0)
- Prevalence of red‐blood‐cell and non‐red‐blood‐cell‐targeted autoantibodies in alloimmunized postpartum women (2020) (0)
- 5 DIFFERENTIAL EFFECT OF PRETRANSPLANT BLOOD TRANSFUSIONS IN INDIVIDUALS WITH AND WITHOUT PREVIOUS HLA ALLOANTIGEN EXPOSURE (2009) (0)
- Blood transfusion and transplantation immunology (2003) (0)
- Strategies to promote engraftment and haematopoietic reconstruction following umbilical cord blood transplantation (2000) (0)
- The Enhancement of Short-Term Engraftment in NOD/Scid Mice after Double Cord Blood Transplantation Is Mediated by CD34+ Cells (2008) (0)
- CYTOMEGALOVIRUS IMMUNITY IN ALLOGENEIC MARROW GRAFTING1 (1985) (0)
- Cost-effectiveness of leukoreduction in major cardiac surgery (2002) (0)
- Bleeding Complications and Transfusion Threshold in Thrombopenic Patients Receiving Antithrombotic Therapy. (2006) (0)
- 6 DETECTION OF MICROCHIMERISM AFTER PRETRANSPLANT BLOOD TRANSFUSIONS (2009) (0)
- Double Umbilical Cord Blood Transplantation Preceded by a Reduced-Intensity Conditioning Regimen: Rapid Induction of Single Donor Chimerism and Highly Predictive Value of Early CD4+ T Cell and NK Cell Predominance (2011) (0)
- Surgery : An Assessment of Postoperati Intraoperative Anemia and Single Red Blood Cell Transfusion During Cardiac ve Outcome Including Patients Refusing Blood Transfusion (2016) (0)
- Lack of detectable platelet autoantibodies is correlated with non-responsiveness to rituximab treatment in ITP patients Running head : Rituximab treatment and autoantibodies in ITP (2017) (0)
- Intravenous immunoglobulin treatment in patients with a chronic inflammatory demyelinating polyneuropathy Clinical and laboratory factors associated with improvement (1991) (0)
- Evaluation of the presence of clinically significant hemolytic disease of the fetus and newborn due to RhD antibodies in multi-ethnic Suriname (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Anneke Brand?
Anneke Brand is affiliated with the following schools: